HealthEquity (NASDAQ:HQY) Stock Price Crosses Above 50 Day Moving Average – Should You Sell?

HealthEquity, Inc. (NASDAQ:HQY) passed above its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $85.20 and traded as high as $85.63. HealthEquity shares last traded at $83.43, with a volume of 715,138 shares.

Analysts Set New Price Targets

A number of research analysts recently commented on HQY shares. KeyCorp restated an “overweight” rating on shares of HealthEquity in a research note on Tuesday, May 26th. Deutsche Bank Aktiengesellschaft raised their target price on HealthEquity from $120.00 to $128.00 and gave the company a “buy” rating in a research note on Thursday, March 19th. Wall Street Zen raised shares of HealthEquity from a “hold” rating to a “buy” rating in a report on Saturday, June 6th. Citigroup restated a “market outperform” rating on shares of HealthEquity in a research report on Monday, June 1st. Finally, BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and increased their price objective for the stock from $85.00 to $105.00 in a report on Thursday, April 9th. One analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating, one has assigned a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat, HealthEquity currently has an average rating of “Moderate Buy” and a consensus target price of $110.57.

HealthEquity Stock Down 1.8%

The company has a debt-to-equity ratio of 0.46, a quick ratio of 3.44 and a current ratio of 3.44. The company has a market cap of $6.97 billion, a P/E ratio of 31.25, a P/E/G ratio of 1.43 and a beta of 0.21. The stock has a 50 day moving average price of $85.20 and a 200 day moving average price of $84.74.

HealthEquity (NASDAQ:HQY) last announced its earnings results on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating the consensus estimate of $1.11 by $0.13. The business had revenue of $354.64 million during the quarter, compared to analysts’ expectations of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business’s quarterly revenue was up 7.2% compared to the same quarter last year. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Research analysts expect that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.

Insider Transactions at HealthEquity

In other news, EVP Michael Henry Fiore sold 3,142 shares of the company’s stock in a transaction on Friday, May 29th. The stock was sold at an average price of $95.00, for a total transaction of $298,490.00. Following the completion of the sale, the executive vice president directly owned 59,113 shares of the company’s stock, valued at $5,615,735. This represents a 5.05% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of the company’s stock in a transaction dated Thursday, May 28th. The shares were sold at an average price of $90.00, for a total transaction of $219,510.00. Following the sale, the director directly owned 19,733 shares of the company’s stock, valued at $1,775,970. This represents a 11.00% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 13,081 shares of company stock valued at $1,193,000 in the last quarter. Insiders own 1.60% of the company’s stock.

Institutional Inflows and Outflows

Several large investors have recently bought and sold shares of HQY. Sivia Capital Partners LLC acquired a new position in shares of HealthEquity in the 2nd quarter valued at about $306,000. Arrowstreet Capital Limited Partnership acquired a new position in shares of HealthEquity during the 2nd quarter worth $4,747,000. Marshall Wace LLP bought a new position in HealthEquity during the second quarter valued at about $5,483,000. Amundi raised its stake in shares of HealthEquity by 9.3% in the 2nd quarter. Amundi now owns 30,203 shares of the company’s stock valued at $3,059,000 after acquiring an additional 2,574 shares in the last quarter. Finally, Jump Financial LLC bought a new position in shares of HealthEquity in the second quarter valued at approximately $449,000. 99.55% of the stock is owned by institutional investors and hedge funds.

About HealthEquity

HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.

Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.